Country: Malasja
Lingwa: Ingliż
Sors: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
DICLOFENAC SODIUM
KOMEDIC SDN BHD
DICLOFENAC SODIUM
10Pieces Pieces; 100Pieces Pieces
MEDOCHEMIE LTD (COGOLS FACILITY)
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ ALMIRAL SUPPOSITORIES Diclofenac Sodium (100mg) 1 WHAT IS IN THIS LEAFLET 1. What Almiral Suppositories is used for 2. How Almiral Suppositories works 3. Before you use Almiral Suppositories 4. How to use Almiral Suppositories 5. While you are using it 6. Side effects 7. Storage and disposal of Almiral Suppositories 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of Revision WHAT ALMIRAL SUPPOSITORIES IS USED FOR Almiral Suppositories relieve pain, reduce swelling and ease inflammation in conditions affecting the joints, muscles and tendons. HOW ALMIRAL SUPPOSITORIES WORKS Almiral Suppositories contains diclofenac sodium which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDS relieves the symptoms of inflammation, such as pain and swelling, by blocking the production of the molecules (prostaglandins) responsible for pain and inflammation. BEFORE YOU USE ALMIRAL SUPPOSITORIES _- When you must not use it _ Do not use Almiral Suppositories if you: - are allergic to diclofenac sodium, aspirin, ibuprofen, other NSAID, or any of the other ingredients of this medicine (listed in section 6). Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic type reaction. - have ulcer in stomach or digestive tract. - have had stomach or bowel problems after you have taken other NSAIDs. - have severe heart, kidney or liver failure. - have any heart problem or blood vessel blockage have or have had problems with your blood circulation (peripheral arterial disease). - are more than six months pregnant. - have rectal inflammation. _ _ Tell your doctor if you recently had or you are going to have a surgery of the stomach or intestinal tract before receiving/taking/using Almiral Suppositories, as Almiral Suppositories can sometimes worsen wound healing in your gut after surgery. _Pregnancy and Lactation _ If you are Aqra d-dokument sħiħ
1 ALMIRAL – PACKAGE INSERT 1. NAME OF THE MEDICINAL PRODUCT Almiral 100mg suppositories 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Almiral suppositories contain 100 mg of Diclofenac sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suppositories Almiral suppositories are white, smooth, homogenous, torpedo-shaped suppositories, for rectal administration. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Treatment of: • rheumatoid arthritis, • osteoarthritis, • ankylosing spondylitis Almiral suppositories are not indicated for use in children. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION One suppository daily usually administered at night. In more severe cases combined therapy with tablets is recommended. The daily dose should not exceed 150mg. As a general recommendation, the dose should be individually adjusted. Adverse effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). ESTABLISHED CARDIOVASCULAR DISEASE OR SIGNIFICANT CARDIOVASCULAR RISK FACTORS Treatment with diclofenac is generally not recommended in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension, or significant risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus and smoking) should be treated with diclofenac only after careful consideration and only at doses ≤100mg daily if treated for more than 4 weeks (see section 4.4). Method of administration Not to be taken by mouth, as per rectal administration only. The suppositories should be inserted well into the rectum. It is recommended to insert the suppositories after passing stools. 4.3. CONTRAINDICATIONS • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Active, gastric or intestinal ulcer, bleeding or perforation. • History of gastrointestinal bleeding or perforation, rel Aqra d-dokument sħiħ